IEC 81001-5-1: 2021 and Medical Device Security

Updated October 26, 2024 IEC 81001-5-1:2021 matters because medical device cybersecurity cannot be bolted on after design freeze. The standard sets expectations for secure product development of health software and software used in medical devices, pushing manufacturers to build security into the lifecycle instead of treating it like a documentation exercise.

Key Takeaways

• Integrates security into the entire product lifecycle.
• Requires documented, repeatable secure development processes.
• Emphasizes active risk management for software security.
• Covers requirements, architecture, verification, and maintenance.
• Helps prepare for FDA cybersecurity expectations.
• Prioritizes evidence from actual development work.

Table of Contents

• Key Takeaways
• What IEC 81001-5-1:2021 Covers
• Core Elements Manufacturers Need to Address
• What Changed in the 2021 Edition
• What This Means for Device Manufacturers
• Achieving Compliance Without Checklist Theater
• Why Compliance Is Worth the Effort
• Where the Standard Is Headed

Why this matters

IEC 81001-5-1:2021 matters because medical device cybersecurity is critical and cannot be merely an afterthought. This standard sets clear expectations for secure product development, pushing manufacturers to embed security throughout the entire lifecycle rather than treating it solely as a documentation requirement. Adherence to IEC 81001-5-1 directly supports compliance with the FDA's "Cybersecurity in Medical Devices" Final Guidance dated February 3, 2026, which emphasizes a Security by Design approach and premarket submission requirements for cybersecurity. The FDA expects manufacturers to demonstrate that cybersecurity is an integral part of their quality management system, aligning with principles found in ISO 13485 and risk management per ISO 14971. Furthermore, following IEC 81001-5-1 helps manufacturers prepare for evolving regulatory landscapes and industry best practices such as those outlined by AAMI TIR97. It provides a structured framework for proving that security is a continuous part of design, implementation, verification, release, and ongoing maintenance activities, thereby enhancing patient safety and device trustworthiness.

What IEC 81001-5-1:2021 Covers

IEC 81001-5-1:2021 is part of the IEC 81001 family and focuses on secure product development for health software and software contained in medical devices. For manufacturers, that means the standard is not just about whether a device works as intended. It is about whether the organization developing that device has defined, repeatable processes for building software that is safer and more secure.

That distinction matters. Too many teams treat cybersecurity as a penetration test near the end of development or as a set of artifacts assembled for regulators. IEC 81001-5-1 pushes against that mindset by tying security work to the product lifecycle.

The standard aligns well with broader expectations around managing risks associated with the development and production of medical devices. It gives manufacturers a structure for showing that security is part of design, implementation, verification, release, and maintenance.

Core Elements Manufacturers Need to Address

General requirements

IEC 81001-5-1 expects manufacturers to establish and maintain a secure development process. That includes documented procedures, assigned responsibilities, and evidence that the process is actually followed.

This is where many organizations stumble. A policy library is not the same as a functioning secure development lifecycle. If engineering, quality, and regulatory teams are not working from the same set of requirements, gaps will show up in verification, traceability, and postmarket response.

Risk management throughout the lifecycle

Risk management is central to the standard. Security hazards need to be identified, evaluated, controlled, and revisited as the device changes over time. That should sound familiar to any manufacturer already working under ISO 14971, but IEC 81001-5-1 makes clear that software security risks need disciplined treatment, not hand-waving.

That means threat-informed analysis, documented control decisions, and evidence that mitigations were implemented and tested. It also means looking beyond safety-only thinking. A cybersecurity weakness may not look like a traditional safety issue at first, but in connected medical devices, that separation often collapses quickly.

Manufacturers that already perform potential hazards analysis should make sure cybersecurity hazards are not being forced into a purely operational or IT bucket. For regulated devices, that is a mistake.

Software lifecycle controls

Because software drives device behavior, the standard puts real weight on lifecycle controls. Requirements management, architecture, verification, validation, configuration management, issue handling, and maintenance all matter.

Security failures usually come from ordinary engineering breakdowns: unclear requirements, untracked changes, inherited third-party code, weak verification, or poor patch planning. IEC 81001-5-1 addresses those realities by expecting manufacturers to treat secure software development as an engineering discipline, not a side task for one security specialist.

What Changed in the 2021 Edition

The 2021 edition sharpened the focus on secure product development and made the expectations more usable for modern medical software environments. As devices become more connected, more distributed, and more dependent on software, manufacturers need standards that reflect how products are actually built and maintained.

One important shift is the stronger emphasis on process maturity across the full product lifecycle. Security is not limited to initial release. It extends into maintenance, updates, vulnerability handling, and coordination across suppliers and integrated systems.

That matters for manufacturers building products with network connectivity, cloud dependencies, mobile components, diagnostic platforms, and monitoring systems. These are not edge cases anymore. They are standard product architectures.

What This Means for Device Manufacturers

If your team designs or produces software-enabled medical devices, IEC 81001-5-1 should affect how you work day to day. It may require changes to development procedures, design reviews, supplier controls, verification planning, and defect handling.

It may also expose uncomfortable truths. For example:

• security requirements are missing or too vague
• architecture decisions are not linked to threat considerations
• third-party software is poorly tracked
• vulnerability handling starts after release instead of during development
• evidence for security claims is scattered across teams

Those are not minor process issues. They turn into regulatory issues, product risk, and expensive remediation.

For manufacturers preparing FDA submissions, this standard is also useful because it supports the kind of disciplined security process the FDA increasingly expects to see. While conformity to IEC 81001-5-1 is not a shortcut to clearance or approval, it can strengthen the story you tell FDA reviewers about how cybersecurity is built into your quality system and product lifecycle.

Achieving Compliance Without Checklist Theater

See also: IEC 81001-5-1 vs AAMI SW96: Which Standard for Your SPDF?, MedTech Cyber Standards Every Device Team Must Know, and IEC 80001-1: Enhancing Medical Device Cybersecurity.

Compliance with IEC 81001-5-1:2021 should not be reduced to a gap assessment spreadsheet and a few updated SOPs. If the process is not changing engineering behavior, it is probably not doing much.

A practical path usually includes:

• defining a secure development lifecycle that maps to actual engineering work
• integrating security requirements into product and software requirements
• performing repeatable risk analysis tied to system design
• establishing verification activities for security controls
• documenting configuration, change, and release controls
• planning for vulnerability intake, triage, remediation, and disclosure after release
• ensuring suppliers and software components are governed, not assumed safe

Documentation still matters. So do testing and traceability. But evidence should come from real work performed during development, not from retroactive cleanup before an audit or submission.

Why Compliance Is Worth the Effort

Done well, alignment with IEC 81001-5-1 improves more than audit readiness. It helps manufacturers build devices that are easier to defend, easier to maintain, and less likely to generate avoidable postmarket problems.

There are business benefits too. Stronger development discipline reduces rework. Clearer evidence supports regulatory submissions. Better vulnerability handling improves trust with customers, partners, and internal stakeholders.

And yes, it can help with market credibility. But that should be the byproduct, not the goal. The real value is fewer preventable security failures in deployed devices.

Where the Standard Is Headed

IEC 81001-5-1 will keep moving in the same direction the industry is moving: more connected systems, more software dependencies, more postmarket security expectations, and less tolerance for shallow security claims.

Future revisions will likely continue to pressure manufacturers to handle cybersecurity as a lifecycle responsibility tied to interoperability, remote access, data flows, software updates, and coordinated vulnerability management. That is especially relevant as devices increasingly incorporate Internet of Things (IoT) capabilities, cloud services, and AI-enabled functions.

The manufacturers that will handle those changes best are the ones building repeatable security practices now. Not just policies. Not just templates. Actual operational discipline across engineering, quality, regulatory, and postmarket teams.

IEC 81001-5-1:2021 is a useful standard because it forces the right question: can you show that security was engineered into the device lifecycle? If the answer is shaky, that is the work to fix.

Blue Goat Cyber helps medical device manufacturers build that evidence the right way, through penetration testing, HIPAA compliance support, FDA compliance support, and medical device cybersecurity services grounded in how products are designed, tested, and reviewed. Contact us today for cybersecurity help.

How Blue Goat approaches this

Blue Goat Cyber helps medical device manufacturers implement and demonstrate compliance with IEC 81001-5-1:2021. Our team, comprised of cybersecurity experts with certifications like CISSP and OSCP, including ex-military red team members, focuses on practical, evidence-based approaches. We assist in establishing a repeatable secure development lifecycle (SDLC) tailored to your specific product and organizational needs, ensuring security is integrated from conception to post-market. Rather than simply checking boxes, we prioritize actionable processes that genuinely improve security posture and provide the necessary objective evidence for regulatory submissions. We support the creation of required documentation, conduct thorough security testing, and facilitate the adoption of secure coding practices. Our services are designed to streamline your regulatory journey. If the FDA raises cybersecurity deficiencies after our submission, we resolve them at no additional cost. Discover how we can assist with your premarket needs: FDA Premarket Cybersecurity Services.

FAQ

What is the purpose of IEC 81001-5-1:2021?

The purpose of IEC 81001-5-1:2021 is to provide a framework for medical device manufacturers to integrate cybersecurity into the secure product development lifecycle of health software and software in medical devices. It aims to ensure that security is built in from the start, rather than added later.

Does IEC 81001-5-1:2021 apply to all medical devices?

This standard specifically applies to health software and software components used within medical devices. It is especially relevant for connected devices, those using cloud services, or those with significant software-driven functionality.

How does IEC 81001-5-1:2021 relate to FDA requirements?

While not directly an FDA regulation, conformity to IEC 81001-5-1:2021 can strengthen a manufacturer's FDA submission by demonstrating a disciplined approach to cybersecurity within their quality system. The FDA's February 3, 2026 premarket cybersecurity guidance aligns with many principles found in this standard.

What are the core elements of IEC 81001-5-1:2021?

Key elements include establishing a secure development process, implementing risk management across the entire product lifecycle for security hazards, and applying specific software lifecycle controls like secure requirements management, architecture, verification, and maintenance.

Is compliance with IEC 81001-5-1:2021 mandatory?

Compliance with IEC 81001-5-1:2021 is not universally mandatory but is widely recognized as a critical benchmark for secure medical device development. Regulators, including the FDA, consider such standards as evidence of a manufacturer's commitment to cybersecurity.

How does compliance benefit manufacturers beyond regulatory checks?

Beyond regulatory compliance, IEC 81001-5-1:2021 alignment leads to more defensible and maintainable devices, reduces rework, improves trust with customers, and mitigates postmarket security problems, ultimately lowering overall product risk.

Related: The Rising Tide of Cyber Threats in Medical Devices: Understanding the Risks

LinkedIn Youtube Instagram Twitter

About the author

Christian Espinosa, CISSP, Founder, Blue Goat Cyber. Christian leads a team focused exclusively on medical device cybersecurity for FDA premarket submissions and postmarket compliance. Read more about Christian.